Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.SSE: 603707

Announcement on Obtaining U.S. FDA Approval for Vitamin B1 Injection of Subsidiary

· Issued by Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/nanjing-king-friend-biochemical-pharmaceutical-co-ltdannouncement-on-obtaining-us-fda-approval-for-vitamin-b1-injection-of-subsidiary

Announcement on Obtaining U.S. FDA Approval for Vitamin B1 Injection of Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. on 6ix

Earlier from Nanjing King-friend Biochemical Pharmaceutical

Later from Nanjing King-friend Biochemical Pharmaceutical

All Nanjing King-friend Biochemical Pharmaceutical news releases